empower pharmacy lawsuit semaglutide Ozempic Study Finds Mental Health Risks Potentially Linked To Drug Empower Pharmacy's FDA violations raise

10.1186/1475-2891-9-42 61 LandreneauJ

The FDA includes deep discounts or prices that seem too good to be true among its published consumer red flags for telehealth services selling GLP-1 products, alongside claims that a compounded drug is the same as an approved drug, absence of prescriber screening, and no licensed doctor reachable after delivery

Increasingly, employees are telling their employers that they want access to these medications, and many employers would like to offer plans that cover them

Are side effects worrisome

Ozempic is designed for the treatment of type 2 diabetes at doses of 0.5 to 1 mg weekly

GLP-1 medications can affect your salivary glands, reducing the amount of saliva your mouth produces